# Myeloma Registry Platform (MYRIAM)

> **NCT03308474** · — · RECRUITING · sponsor: **iOMEDICO AG** · enrollment: 2200 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Routine care as per site standard.

## Key facts

- **NCT ID:** NCT03308474
- **Lead sponsor:** iOMEDICO AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-09-25
- **Primary completion:** 2026-12
- **Final completion:** 2028-12
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2026-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03308474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03308474, "Myeloma Registry Platform (MYRIAM)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03308474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*